Cardiovascular-Kidney-Metabolic (CKM) Syndrome

New Therapies in the Prevention of Cardiac Damage in Patientswith CKM Syndrome

by Prateek Chopra | June 3, 2026 | Cardiology Conferences | ESH 2026 Clinical Context: Cardiovascular-kidney-metabolic (CKM) syndrome encompasses overlapping progression of cardiovascular disease, chronic kidney disease, obesity, diabetes, and hypertension, resulting in persistent myocardial injury and increased heart failure risk. Contemporary management focuses on integrated therapies targeting cardio-renal-metabolic pathways to prevent progressive cardiac damage. Key Pathophysiology & Mechanisms: Emerging Therapeutic […]

New Therapies in the Prevention of Cardiac Damage in Patientswith CKM Syndrome Read Post »

Leave a Comment / ESH Day 1 / / / , , , ,

Time for Change: Can Lifestyle Interventions Prevent theEvolution of Cardiac Damage in Patients with CKM Syndrome?

by Prateek Chopra | June 2, 2026 | Cardiology Conferences | ESH 2026 Study Objective: Evaluate whether lifestyle interventions can prevent progression of cardiac damage across different stages of CKM syndrome. Evidence Across CKM Stages: Stage 0 (Pre-risk / Children): Stage 2 (Metabolic Risk / Subclinical Disease): Stage 3 (Silent Cardiac Damage): Stage 4 (Established CVD / Secondary Prevention): Clinical Implications

Time for Change: Can Lifestyle Interventions Prevent theEvolution of Cardiac Damage in Patients with CKM Syndrome? Read Post »

Leave a Comment / ESH Day 1 / / / , , , ,
Scroll to Top